Evinova and Merck KGaA Partner to Advance AI Clinical Development
BAAR, Switzerland, July 29, 2026 Evinova, an AI-native clinical development technology company within the AstraZeneca group, has entered into...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
BAAR, Switzerland, July 29, 2026 Evinova, an AI-native clinical development technology company within the AstraZeneca group, has entered into...
